- Design
- Comparison across inception cohorts
- Population
- 373 participants: HFE genotypes with and without iron overload, and controls
- Primary outcome
- Fulfilment of EULAR haemochromatosis arthropathy classification criteria
- Effect
- 43% other HFE genotypes and 22% C282Y without overload vs 7% controls
This study drew on EULAR haemochromatosis arthropathy inception cohorts: 154 C282Y homozygotes with iron overload, 27 without, 72 people with other HFE genotypes irrespective of iron status, and 120 controls with osteoarthritis or calcium pyrophosphate disease without iron overload.
Arthropathy meeting the EULAR classification criteria was present in 71% of iron-loaded C282Y homozygotes, 22% of those without overload, 43% of other HFE genotypes including H63D, and 7% of controls. Within the non-haemochromatosis groups, ferritin and transferrin saturation did not predict the arthropathy.
The authors propose 'HFE-associated arthropathy without genetic haemochromatosis' for metacarpophalangeal or ankle disease in any HFE genotype. The non-haemochromatosis groups were selected from patients with unexplained joint pain, so prevalence here overstates what would be found in the general population.
- Consider HFE genotyping in unexplained second and third MCP or ankle arthropathy
- Do not exclude an HFE-related cause because ferritin and transferrin saturation are normal
- Look for chondrocalcinosis and hook-like osteophytes on hand radiographs
- Manage iron overload when present; the joint disease may persist regardless
Why it matters
Separates the joint disease from the iron, which changes who gets tested.
Don't overread it
Patients were selected for joint pain; this does not give the arthropathy risk for all HFE carriers.
The statistics, in plain English
The odds ratios of about 1.0 for ferritin and transferrin saturation mean iron levels made no measurable difference to whether arthropathy was present. Because patients in the HFE groups were selected for joint symptoms, the prevalence figures are higher than in unselected carriers.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for rheumatology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free